Von Willebrand disease (vWD) is the most common hereditary disorder affecting coagulation. Patients with this disorder are at a higher risk of postoperative complications after dental surgery. This article discusses the successful treatment for a patient with vWD undergoing implant therapy.
A young 21-year-old patient with vWD lost tooth #30 because of caries and required implant therapy. Through collaboration with a hematologist administering prophylactic desmopressin (DDAVP), the implant surgery was performed without any postoperative complications. The implant successfully integrated and was restored into function. The successful outcome met expectations after careful planning and execution.
Collaboration with the appropriate medical providers, as well as treatment modifications for surgical procedures during implant therapy, is necessary for successful treatment of a patient with von Willebrand disorder.
*Private Practice, Fairfield County, Connecticut.
†Postdoctoral Director, Division of Periodontics, Section of Oral, Diagnostic & Rehabilitation Sciences, Columbia University College of Dental Medicine, New York, NY.
Reprint requests and correspondence to: Phillip Kang, DDS, Division of Periodontics, Section of Oral, Diagnostic, and Rehabilitation Sciences, Columbia University College of Dental Medicine, #PH7E-124, 630 W. 168 Street, New York, NY 10032, Phone: 212-342-3008, Fax: 212-305-931, E-mail: email@example.com